Cargando…
Identification of novel DNA methylation inhibitors via a two-component reporter gene system
BACKGROUND: Targeting abnormal DNA methylation represents a therapeutically relevant strategy for cancer treatment as demonstrated by the US Food and Drug Administration approval of the DNA methyltransferase inhibitors azacytidine and 5-aza-2'-deoxycytidine for the treatment of myelodysplastic...
Autores principales: | Lin, Yi-Shiuan, Shaw, Arthur Y, Wang, Shi-Gang, Hsu, Chia-Chen, Teng, I-Wen, Tseng, Min-Jen, Huang, Tim HM, Chen, Ching-Shih, Leu, Yu-Wei, Hsiao, Shu-Huei |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025941/ https://www.ncbi.nlm.nih.gov/pubmed/21219604 http://dx.doi.org/10.1186/1423-0127-18-3 |
Ejemplares similares
-
Changes in DNA methylation are associated with the development of drug resistance in cervical cancer cells
por: Chen, Chih-Cheng, et al.
Publicado: (2015) -
Dihydrocoumarin, an HDAC Inhibitor, Increases DNA Damage Sensitivity by Inhibiting Rad52
por: Chen, Chin-Chuan, et al.
Publicado: (2017) -
HIC1 and RassF1A Methylation Attenuates Tubulin Expression and Cell Stiffness in Cancer
por: Chen, Chih-Cheng, et al.
Publicado: (2018) -
A prognostic predictor panel with DNA methylation biomarkers for early-stage lung adenocarcinoma in Asian and Caucasian populations
por: Kuo, I-Ying, et al.
Publicado: (2016) -
Phosphodiesterase Type 5 (PDE5) Inhibitors Sensitize Topoisomerase II Inhibitors in Killing Prostate Cancer Through PDE5-Independent Impairment of HR and NHEJ DNA Repair Systems
por: Chang, Jo-Fan, et al.
Publicado: (2019)